⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALLO News
Allogene Therapeutics, Inc. Common Stock
Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T
globenewswire.com
ALLO
Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis
globenewswire.com
ALLO
CLLS
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
globenewswire.com
ALLO
Allogene Therapeutics Reports Third Quarter 2025 Financial Results and Business Update
globenewswire.com
ALLO
Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
globenewswire.com
ALLO
Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update
globenewswire.com
ALLO